SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Young-Joo Yang, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Assessment of current criteria for primary nonresponse in chronic hepatitis B patients receiving entecavir therapy, Hepatology, 2014, 59, 4
  2. 2
    D. K.-H. Wong, M. Kopaniszen, K. Omagari, Y. Tanaka, D. Y.-T. Fong, W.-K. Seto, J. Fung, F.-Y. Huang, A.-y. Zhang, I. F.-N. Hung, C.-L. Lai, M.-F. Yuen, Effect of Hepatitis B Virus Reverse Transcriptase Variations on Entecavir Treatment Response, Journal of Infectious Diseases, 2014, 210, 5, 701

    CrossRef

  3. 3
    Gang Huang, Yuan Yang, Feng Shen, Ze-ya Pan, Si-yuan Fu, Wan Yee Lau, Wei-ping Zhou, Meng-chao Wu, Early Viral Suppression Predicts Good Postoperative Survivals in Patients with Hepatocellular Carcinoma with a High Baseline HBV-DNA Load, Annals of Surgical Oncology, 2013, 20, 5, 1482

    CrossRef

  4. 4
    Eleftherios Michailidis, Karen A. Kirby, Atsuko Hachiya, Wangdon Yoo, Sun Pyo Hong, Soo-Ok Kim, William R. Folk, Stefan G. Sarafianos, Antiviral therapies: Focus on hepatitis B reverse transcriptase, The International Journal of Biochemistry & Cell Biology, 2012, 44, 7, 1060

    CrossRef

  5. 5
    Chao Wei Hsu, You Chen Chao, Chuan Mo Lee, Ting Tsung Chang, Yi Cheng Chen, Efficacy of telbivudine in Taiwanese chronic hepatitis B patients compared with GLOBE extension study and predicting treatment outcome by HBV DNA kinetics at Week 24, BMC Gastroenterology, 2012, 12, 1, 178

    CrossRef

  6. 6
    J. W. Shin, S. W. Jung, B. R. Park, C. J. Kim, J. B. Eum, B. G. Kim, I. D. Jeong, S.-J. Bang, S.-H. Lee, S. R. Kim, N. H. Park, Prediction of response to entecavir therapy in patients with HBeAg-positive chronic hepatitis B based on on-treatment HBsAg, HBeAg and HBV DNA levels, Journal of Viral Hepatitis, 2012, 19, 10
  7. 7
    J. Inoue, Y. Ueno, Y. Wakui, H. Niitsuma, K. Fukushima, Y. Yamagiwa, M. Shiina, Y. Kondo, E. Kakazu, K. Tamai, N. Obara, T. Iwasaki, T. Shimosegawa, Four-year study of lamivudine and adefovir combination therapy in lamivudine-resistant hepatitis B patients: influence of hepatitis B virus genotype and resistance mutation pattern, Journal of Viral Hepatitis, 2011, 18, 3
  8. 8
    A. Ong, V. W.-S. Wong, G. L.-H. Wong, H.-Y. Chan, C.-H. Tse, H. L.-Y. Chan, Management options for lamivudine-resistant chronic hepatitis B patients with suboptimal virological suppression by adefovir, Alimentary Pharmacology & Therapeutics, 2011, 34, 8
  9. 9
    Y. Liang, J. Jiang, M. Su, Z. Liu, W. Guo, X. Huang, R. Xie, S. Ge, J. Hu, Z. Jiang, M. Zhu, V. W.-S. Wong, H. L.-Y. Chan, Predictors of relapse in chronic hepatitis B after discontinuation of anti-viral therapy, Alimentary Pharmacology & Therapeutics, 2011, 34, 3
  10. 10
    Moon-Chan Kim, Seok Won Jung, Jung Woo Shin, Neung Hwa Park, The Level of HBV DNA at Month 12 Is an Important Predictor of Virological Breakthrough During Adefovir Monotherapy in Chronic Hepatitis B Patients with Lamivudine Resistance, Digestive Diseases and Sciences, 2011, 56, 4, 1215

    CrossRef

  11. 11
    Su Rin Shin, Kwang Cheol Koh, Geum-Youn Gwak, Moon Seok Choi, Joon Hyoek Lee, Seung Woon Paik, Byung Chul Yoo, A Low Viral Load Predicts a Higher Initial Virologic Response to Adefovir in Patients with Lamivudine-Resistant Chronic Hepatitis B, Gut and Liver, 2010, 4, 4, 530

    CrossRef

  12. 12
    Themistoklis G Vassiliadis, Olga Giouleme, Georgios Koumerkeridis, Haralabos Koumaras, Konstantinos Tziomalos, Kalliopi Patsiaoura, Nikolaos Grammatikos, Alexandros Mpoumponaris, Dimitrios Gkisakis, Konstantinos Theodoropoulos, Athanasia Panderi, Panagiotis Katsinelos, Nikolaos Eugenidis, Adefovir plus lamivudine are more effective than adefovir alone in lamivudine-resistant HBeAg- chronic hepatitis B patients: A 4-year study, Journal of Gastroenterology and Hepatology, 2010, 25, 1
  13. 13
    Han Jak Ryu, Jung Min Lee, Sang Hoon Ahn, Do Young Kim, Myoung Ha Lee, Kwang-Hyub Han, Chae Yoon Chon, Jun Yong Park, Efficacy of adefovir add-on lamivudine rescue therapy compared with switching to entecavir monotherapy in patients with lamivudine-resistant chronic hepatitis B, Journal of Medical Virology, 2010, 82, 11
  14. 14
    Yongwei Li, Mingfen Zhu, Yunwei Guo, Wei Chen, Gang Li, Full-length hepatitis B virus sequences from naïve patients with fluctuation of viral load during ADV monotherapy, Virus Genes, 2010, 40, 2, 155

    CrossRef

  15. 15
    Paulo Roberto Abrão Ferreira, Simone de Barros Tenore, Response predictors to treatment with pegylated interferon in chronic hepatitis B, The Brazilian Journal of Infectious Diseases, 2010, 14, 5, 519

    CrossRef

  16. You have free access to this content16
    H. Y. Lu, L. W. Zhuang, Y. Y. Yu, C. W. Si, Virological response to antiviral therapy at week 12 indicates a great reduction of intrahepatic hepatitis B virus DNA and cccDNA in HBeAg-positive chronic hepatitis B patients, Journal of Viral Hepatitis, 2010, 17,
  17. 17
    Henry Lik-Yuen Chan, Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong, Journal of Hepatology, 2009, 51, 6, 1088

    CrossRef

  18. 18
    Stefan Zeuzem, Edward Gane, Yun-Fan Liaw, Seng G. Lim, Adrian DiBisceglie, Maria Buti, Anuchit Chutaputti, Jens Rasenack, Jinlin Hou, Christopher O’Brien, Tuan T. Nguyen, Jidong Jia, Thierry Poynard, Bruce Belanger, Weibin Bao, Nikolai V. Naoumov, Baseline characteristics and early on-treatment response predict the outcomes of 2years of telbivudine treatment of chronic hepatitis B, Journal of Hepatology, 2009, 51, 1, 11

    CrossRef

  19. 19
    M. H. Nguyen, E. B. Keeffe, Chronic hepatitis B: early viral suppression and long-term outcomes of therapy with oral nucleos(t)ides, Journal of Viral Hepatitis, 2009, 16, 3
  20. 20
    Yoon-Seon Lee, Young-Hwa Chung, Jeong A. Kim, Sung Eun Kim, Jung Woo Shin, Kang Mo Kim, Young-Suk Lim, Neung Hwa Park, Han Chu Lee, Yung Sang Lee, Dong Jin Suh, Hepatitis B virus with the rtL80V/I mutation is associated with a poor response to adefovir dipivoxil therapy, Liver International, 2009, 29, 4
  21. 21
    Jenny L. Limquiaco, John Wong, Vincent W.S. Wong, Grace L.H. Wong, Chi-Hang Tse, Hoi-Yun Chan, Katherine Y.Y. Kwan, Paul B.S. Lai, Henry L.Y. Chan, Lamivudine monoprophylaxis and adefovir salvage for liver transplantation in chronic hepatitis B: A seven-year follow-up study, Journal of Medical Virology, 2009, 81, 2
  22. 22
    Grace L.-H. Wong, Henry L.-Y. Chan, Predictors of Treatment Response in Chronic Hepatitis B, Drugs, 2009, 69, 16, 2167

    CrossRef

  23. 23
    Holger G. Hass, Thomas Bock, Oliver Nehls, Stephan Kaiser, Rapid HBV DNA decrease (week 12) is an important prognostic factor for first-line treatment with adefovir dipivoxil for chronic hepatitis B, Journal of Gastroenterology, 2009, 44, 8, 871

    CrossRef

  24. 24
    Vincent Wai-Sun Wong, Henry Lik-Yuen Chan, Severe acute exacerbation of chronic hepatitis B: A unique presentation of a common disease, Journal of Gastroenterology and Hepatology, 2009, 24, 7
  25. 25
    Yanni YN Lui, Henry LY Chan, A review of telbivudine for the management of chronic hepatitis B virus infection, Expert Opinion on Drug Metabolism & Toxicology, 2008, 4, 10, 1351

    CrossRef

  26. 26
    James Fung, Ching-Lung Lai, Man-Fung Yuen, New paradigms for the treatment of chronic hepatitis B, Journal of Gastroenterology and Hepatology, 2008, 23, 8pt1
  27. 27
    Nancy Leung, Recent data on treatment of chronic hepatitis B with nucleos(t)ide analogues, Hepatology International, 2008, 2, 2, 163

    CrossRef